NCT02962362

Brief Summary

Study to collect outcomes data for patients who are undergoing an Exactech Optetrak® primary total knee replacement using the Exactech Guided Personalized Surgery (eGPS®) manufactured or distributed by (Exactech, Gainesville, Florida, USA).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
73

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 8, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 11, 2016

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2019

Completed
2.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2021

Completed
Last Updated

September 1, 2022

Status Verified

August 1, 2022

Enrollment Period

2.9 years

First QC Date

November 8, 2016

Last Update Submit

August 29, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Hospital for Special Surgery knee score (HSS)

    total score, pain, function

    24 Months

  • Oxford Knee Score (OKS)

    function, pain

    24 Months

  • Knee Society Score (KSS)

    total score, pain, function

    24 Months

  • Knee injury and Osteoarthritis Outcome Score (KOOS)

    total score and subscales

    24 Months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

One hundred (100) subjects enrolled up to 4 sites. All subjects will be screened, enrolled and evaluated prospectively and be followed for up to two years. In the event a subject is enrolled and does not have surgery, additional patients may be screened and enrolled to reach the 100 subjects.

You may qualify if:

  • Patient requires a primary Optetrak Logic Total Knee Arthroplasty
  • Patient is skeletally mature with no obvious mechanical defect
  • Patient is mentally capable of completing follow-up visits
  • Patient is 18 years of age or greater at time of surgery
  • Patient will be available for follow-up out to 2 years
  • Patient has consented to participate in the clinical study

You may not qualify if:

  • Patient has a mental or physical condition that may invalidate evaluation of the data
  • Patient is a prisoner
  • Surgery is contraindicated according to the applicable product package insert
  • Patient has a local or systemic infection
  • Patient has a known sensitivity to one or more of the materials in the knee replacement system to be used
  • Patient is pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Exatech, Inc.

Gainesville, Florida, 32653, United States

Location

MeSH Terms

Conditions

Osteoarthritis

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 8, 2016

First Posted

November 11, 2016

Study Start

August 1, 2016

Primary Completion

July 1, 2019

Study Completion

November 1, 2021

Last Updated

September 1, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations